Bioactivity:

CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 _M), with 87% inhibition of SRE activation achieved at 100 _M. This compound also inhibits PC-3 cell migration (IC50: 4.2 _M), as determined by a scratch wound a

CAS nr:

1443437-74-8

Purity:

98%

Molecular Weight:

408,88

SMILES:

O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4

Formula:

C23H21ClN2O3

Pathway:

GPCR/G Protein,MAPK,Cell Cycle/Checkpoint

Target:

Ras,Ras,Rho